Nykode Therapeutics Feed

Land	Norge
Lista	OB Match
Sektor	Hälsovård
Industri	Bioteknik

2024-04-19 06:30:00 Nykode Therapeutics - Annual Report 2023

2024-03-26 15:30:34 Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider +4,67% | 23,7 MNOK

2024-03-21 19:38:41 Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider +1,43% | 18,3 MNOK

2024-03-21 07:00:00 Nykode Therapeutics Announces Topline Conclusions Affirming Prolonged Clinical Benefits from Matured Survival Data in Phase 2 C-02 Trial in Advanced Cervical Cancer +1,66% | 52,9 MNOK

2024-03-21 07:00:00 NYKD: Nykode Therapeutics Announces Topline Conclusions Affirming Prolonged Clinical Benefits from Matured Survival Data in Phase 2 C-02 Trial in Advanced Cervical Cancer +1,66% | 52,9 MNOK

2024-03-19 07:00:00 Nykode Therapeutics Announces Advances in the Inverse Vaccine Platform With the Potential to Treat Autoimmune Diseases -0,70% | 28,5 MNOK

2024-03-19 07:00:00 NYKD: Nykode Therapeutics Announces Advances in the Inverse Vaccine Platform With the Potential to Treat Autoimmune Diseases -0,70% | 28,5 MNOK

2024-03-13 14:57:58 Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider -5,80% | 56,0 MNOK

2024-03-08 16:16:17 Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider +8,31% | 86,9 MNOK

2024-03-08 13:31:02 Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider +8,31% | 86,9 MNOK

2024-03-04 13:11:51 Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider -6,65% | 69,2 MNOK

2024-02-29 16:27:01 Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider -1,95% | 43,0 MNOK

2024-02-28 07:00:00 Nykode Therapeutics - Quarterly report Q4 2023 -5,84% | 75,1 MNOK

2024-02-22 07:00:00 Nykode Therapeutics - invitation to Q4 2023 financial results presentation +1,42% | 13,3 MNOK

2023-12-19 07:00:00 NYKD: Nykode Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference -5,56% | 44,3 MNOK

2023-12-18 21:19:36 NYKD: Financial calendar -5,56% | 44,3 MNOK

2023-12-14 07:00:00 NYKD: Nykode Therapeutics Announces Expansion of Oncology Pipeline Aiming to Reduce the Burden of Colorectal Cancer +9,55% | 71,2 MNOK

2023-12-07 18:00:46 Nykode Therapeutics - Share capital increase from exercise of warrants +1,12% | 14,5 MNOK

2023-11-28 10:49:37 Nykode Therapeutics - Share capital increase from exercise of warrants -2,13% | 38,3 MNOK

2023-11-24 18:20:27 Nykode Therapeutics - Primary insider transaction -4,69% | 25,5 MNOK

2023-11-15 10:30:31 Nykode Therapeutics - Quarterly report Q3 2023 +2,67% | 37,2 MNOK

2023-11-15 07:00:00 Nykode Therapeutics - Quarterly report Q3 2023 +2,67% | 37,2 MNOK

2023-11-10 17:13:28 Nykode Therapeutics - Share capital increase from exercise of warrants -3,01% | 9,48 MNOK

2023-11-09 08:30:00 Nykode Therapeutics - invitation to Q3 2023 financial results presentation -3,04% | 34,1 MNOK

2023-11-07 08:30:00 NYKD: Nykode Therapeutics to Present at Jefferies Healthcare Conference -0,28% | 18,9 MNOK

2023-10-31 15:30:19 Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider +3,43% | 49,9 MNOK

2023-10-31 14:41:11 NYKD: Disclosure of shareholding +3,43% | 49,9 MNOK

2023-10-31 09:16:43 Nykode Therapeutics ASA - New Share Capital Registered +3,43% | 49,9 MNOK

2023-10-30 23:29:48 Nykode Therapeutics ASA - Subsequent Offering Cancelled +3,43% | 49,9 MNOK

2023-10-27 16:15:56 Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider -1,01% | 70,2 MNOK

2023-10-25 17:22:35 Nykode Therapeutics - Mandatory notification of trade by closely associated party of a primary Insider -5,13% | 121 MNOK

2023-10-25 15:32:37 Nykode Therapeutics - Mandatory notification of trade by closely associated party of a primary Insider -11,69% | 689 MNOK

2023-10-25 14:33:14 NYKD: Disclosure of shareholding -11,69% | 689 MNOK

2023-10-25 08:15:07 NYKD: Disclosure of shareholding -11,69% | 689 MNOK

2023-10-25 02:05:53 Nykode Therapeutics ASA - Share Lending by Closely Associated Parties of a Primary Insider -11,69% | 689 MNOK

2023-10-25 01:54:58 Nykode Therapeutics ASA - Key Information Regarding Subsequent Offering +2,55% | 13,9 MNOK

2023-10-25 01:50:15 Nykode Therapeutics ASA - Private Placement Completed +2,55% | 13,9 MNOK

2023-10-24 16:30:54 Nykode Therapeutics ASA - Contemplated Private Placement -11,69% | 689 MNOK

2023-10-23 20:58:43 Nykode Therapeutics - Update on process with the Norwegian Tax Authorities +2,55% | 13,9 MNOK

2023-10-12 16:00:00 Nykode Therapeutics - presentation from the mRNA Cancer Vaccines Summit 2023 in Boston +1,54% | 14,1 MNOK

2023-10-09 06:45:00 NYKD: Nykode Therapeutics to Present at the mRNA Cancer Vaccines Summit 2023 in Boston -3,49% | 21,6 MNOK

2023-10-09 06:45:00 Nykode Therapeutics to Present at the mRNA Cancer Vaccines Summit 2023 in Boston -3,49% | 21,6 MNOK

2023-09-29 07:00:00 NYKD: Nykode Therapeutics Initiates Phase 1/2a Trial of VB10.16 in First Line HPV16-Positive Head and Neck Cancer +0,85% | 38,6 MNOK

2023-09-27 14:00:00 Nykode Therapeutics - presentation from Capital Markets Day in Oslo -5,35% | 27,6 MNOK

2023-09-25 08:30:00 Nykode Therapeutics - Invitation to Capital Markets Day in Oslo on September 27, 2023 -4,21% | 16,7 MNOK

2023-09-20 16:06:50 Nykode Therapeutics Announces Advances in Clinical Pipeline and Research +5,62% | 49,5 MNOK

2023-09-20 16:00:00 NYKD: Nykode Therapeutics Announces Advances in Clinical Pipeline and Research +5,62% | 49,5 MNOK

2023-09-11 10:36:49 NYKD: Nykode Therapeutics to Present at H.C. Wainwright 25th Annual Global Investment Conference +0,50% | 15,8 MNOK

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

2025-02-26	Bokslutskommuniké 2024
2024-11-27	Kvartalsrapport 2024-Q3
2024-08-21	Kvartalsrapport 2024-Q2
2024-05-21	Ordinarie utdelning NYKD 0.00 NOK
2024-05-16	Årsstämma 2024
2024-05-14	Kvartalsrapport 2024-Q1
2024-02-28	Bokslutskommuniké 2023
2023-11-15	Kvartalsrapport 2023-Q3
2023-08-23	Kvartalsrapport 2023-Q2
2023-05-16	Kvartalsrapport 2023-Q1
2023-05-12	Ordinarie utdelning NYKD 0.00 NOK
2023-05-11	Årsstämma 2023
2023-02-28	Bokslutskommuniké 2022
2022-11-23	Kvartalsrapport 2022-Q3
2022-08-24	Kvartalsrapport 2022-Q2
2022-05-16	Kvartalsrapport 2022-Q1
2022-05-13	Ordinarie utdelning NYKD 0.00 NOK
2022-05-12	Årsstämma 2022
2022-03-31	Bokslutskommuniké 2021
2021-12-22	Extra Bolagsstämma 2021
2021-11-17	Kvartalsrapport 2021-Q3
2021-08-26	Kvartalsrapport 2021-Q2
2021-05-12	Kvartalsrapport 2021-Q1
2021-05-06	Ordinarie utdelning NYKD 0.00 NOK
2021-05-05	Årsstämma 2021
2021-04-21	Bokslutskommuniké 2020
2020-11-17	Kvartalsrapport 2020-Q3
2020-08-27	Kvartalsrapport 2020-Q2
2020-07-07	Split NYKD 1:5
2020-07-06	Extra Bolagsstämma
2020-05-12	Kvartalsrapport 2020-Q1
2020-04-22	Extra Bolagsstämma

Nykode Therapeutics

Kalender

Beskrivning

Nykode Therapeutics

Kalender

Beskrivning

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden